Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience

Overview of attention for article published in Blood, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 1 X post from an account with 1,666 followers.

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience https://t.co/KGQYtUy8Kx

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.